Author:
Fujita Masashi,Yamaguchi Rui,Hasegawa Takanori,Shimada Shu,Arihiro Koji,Hayashi Shuto,Maejima Kazuhiro,Nakano Kaoru,Fujimoto Akihiro,Ono Atsushi,Aikata Hiroshi,Ueno Masaki,Hayami Shinya,Tanaka Hiroko,Miyano Satoru,Yamaue Hiroki,Chayama Kazuaki,Kakimi Kazuhiro,Tanaka Shinji,Imoto Seiya,Nakagawa Hidewaki
Funder
Japan Agency for Medical Research and Development
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference55 articles.
1. The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non–small cell lung cancer;Bremnes;J Thorac Oncol,2016
2. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction;Mlecnik;J Clin Oncol,2011
3. Dose-response association of CD8 + tumor-infiltrating lymphocytes and survival time in high-grade serous ovarian cancer;Goode;JAMA Oncol,2017
4. The immune contexture in human tumours: impact on clinical outcome;Fridman;Nat Rev Cancer,2012
5. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy;Cristescu;Science,2018